Oncología Médica Traslacional y Terapia Individualizada del Cáncer

Hamilton, E; Cortes, J; Ozyilkan, O; Chen, SC; Petrakova, K; Manikhas, A; Jerusalem, G; Hegg, R; Huober, J; Chapman, SC; Lu, Y; Hardebeck, MC; Bear, MM; Johnston, EL; Martin, M.

nextMONARCH: Abemaciclib Monotherapy or Combined With Tamoxifen for Metastatic Breast Cancer

Clinical Breast Cancer. 2021; 21(3): 181 Nº de citas: 37 [doi:10.1016/j.clbc.2020.09.011]

Bellmunt, J; Esteban, E; Muro XGD; Sepulveda, JM; Maroto, P; Gallardo, E; Alba AGD; Etxaniz, O; Guix, M; Larriba JLG; Arranz, JA; Redrado, M; Calvo, A.

Pazopanib as Second-line Antiangiogenic Treatment in Metastatic Renal Cell Carcinoma After Tyrosine Kinase Inhibitor (TKI) Failure: A Phase 2 Trial Exploring Immune-related Biomarkers for Testing in the Post-immunotherapy/TKI Era

European Urology Oncology. 2021; 4(3): 502-505 Nº de citas: 6 [doi:10.1016/j.euo.2019.07.014]

Escudero-Vilaplana, V; Collado-Borrell, R; Villanueva-Bueno, C; Alvarez, R; Herranz, A; Sanjurjo, M.

Acute pancreatitis in a patient treated with imatinib and gefitinib

JOURNAL OF ONCOLOGY PHARMACY PRACTICE. 2021; 27(4): 980-983 Nº de citas: 3 [doi:10.1177/1078155220949639]

Garcia-Martin, E; Escudero-Vilaplana, V; Fox, B; Collado-Borrell, R; Marzal-Alfaro, B; Sanchez-Isac, M; Solano-Garzon, ML; del Val, RG; Cano-Gonzalez, JM; de Lucas, NP; Bravo-Guillen, AI; Valero-Salinas, J; Gonzalez-Haba, E; Sanjurjo, M; Martin, M.

Aggressiveness of end-of-life cancer care: what happens in clinical practice?

SUPPORTIVE CARE IN CANCER. 2021; 29(6): 3121-3127 Nº de citas: 8 [doi:10.1007/s00520-020-05828-9]

Garcia-Escobar, I; Brozos-Vazquez, E; Abad, DG; Martinez-Marin, V; Pachon, V; Martin, AJM; Canc Thrombosis Sect Spanish.

Direct oral anticoagulants for the treatment and prevention of venous thromboembolism in patients with cancer: current evidence

Clinical & Translational Oncology. 2021; 23(6): 1034-1046 Nº de citas: 8 [doi:10.1007/s12094-020-02506-4]

Taboada AGM; Lominchar PL; Roman LM; García-Alfonso P; Martin AJM; Rodriguez JAB; Pascual JMA.

Advances in neoadjuvant therapy for resectable pancreatic cancer over the past two decades.

Annals of Hepato-Biliary-Pancreatic Surgery. 2021; 25(2): 179-191 Nº de citas: 17 [doi:10.14701/ahbps.2021.25.2.179]

Loibl, S; Marme, F; Martin, M; Untch, M; Bonnefoi, H; Kim, SB; Bear, H; McCarthy, N; Olive, MM; Gelmon, K; Garcia-Saenz, J; Kelly, CM; Reimer, T; Toi, M; Rugo, HS; Denkert, C; Gnant, M; Makris, A; Koehler, M; Huang-Bartelett, C; Frean, MJL; Colleoni, M; Werutsky, G; Seiler, S; Burchardi, N; Nekljudova, V; von Minckwitz, G.

Palbociclib for Residual High-Risk Invasive HR-Positive and HER2-Negative Early Breast Cancer-The Penelope-B Trial

JOURNAL OF CLINICAL ONCOLOGY. 2021; 39(14): 1518-1530 Nº de citas: 285 [doi:10.1200/JCO.20.03639]

Escobar-Alvarez, Y; de Castro-Carpeno, J; Feyjoo, M; Martin-Algarra, S.

Evaluation of patient quality care in Spain in prevention of nausea and vomiting induced by chemotherapy

Journal of Healthcare Quality Research. 2021; 36(3): 142-149 [doi:10.1016/j.jhqr.2021.01.001]

Majem, M; Manzano, JL; Marquez-Rodas, I; Mujika, K; Munoz-Couselo, E; Perez-Ruiz, E; de la Cruz-Merino, L; Espinosa, E; Gonzalez-Cao, M; Berrocal, A.

SEOM clinical guideline for the management of cutaneous melanoma (2020)

Clinical & Translational Oncology. 2021; 23(5): 948-960 Nº de citas: 20 [doi:10.1007/s12094-020-02539-9]

del Alba, AG; Mendez-Vidal, MJ; Vazquez, S; Castro, E; Climent, MA; Gallardo, E; Gonzalez-Billalabeitia, E; Lorente, D; Maroto, JP; Arranz, JA.

SEOM clinical guidelines for the treatment of advanced prostate cancer (2020)

Clinical & Translational Oncology. 2021; 23(5): 969-979 Nº de citas: 22 [doi:10.1007/s12094-021-02561-5]

Gomez-Espana, MA; Montes, AF; Garcia-Carbonero, R; Mercade, TM; Maurel, J; Martin, AM; Pazo-Cid, R; Vera, R; Carrato, A; Feliu, J.

SEOM clinical guidelines for pancreatic and biliary tract cancer (2020)

Clinical & Translational Oncology. 2021; 23(5): 988-1000 Nº de citas: 40 [doi:10.1007/s12094-021-02573-1]

Alvarez, YE; Bataller, RD; Altozano, JP; Martinez, SR; Alvarez, AS; Cordellat, AB; Vazquez, EB; Jaime, JC; Escobar, IG; Zambrano, CB.

SEOM clinical guidelines for anaemia treatment in cancer patients (2020)

Clinical & Translational Oncology. 2021; 23(5): 931-939 Nº de citas: 21 [doi:10.1007/s12094-021-02580-2]

Verso, M; Munoz, A; Bauersachs, R; Huisman, MV; Mandala, M; Vescovo, G; Becattini, C; Agnelli, G.

Effects of concomitant administration of anticancer agents and apixaban or dalteparin on recurrence and bleeding in patients with cancer-associated venous thromboembolism

EUROPEAN JOURNAL OF CANCER. 2021; 148: 371-381 Nº de citas: 54 [doi:10.1016/j.ejca.2021.02.026]

Martin, M; Mayer, IA; Walenkamp, AME; Lapa, C; Andreeff, M; Bobirca, A.

At the bedside: Profiling and treating patients with CXCR4-expressing cancers

JOURNAL OF LEUKOCYTE BIOLOGY. 2021; 109(5): 953-967 Nº de citas: 27 [doi:10.1002/JLB.5BT1219-714R]

Ferre, AD; Alvarez, RA; Herraez, AC; Jurado, JC; Gonzalez, AE; Martin-Broto, J; Marin, VM; Vega, AM; Garcia, AS; Morales, CV.

SEOM Clinical Guideline of management of soft-tissue sarcoma (2020)

Clinical & Translational Oncology. 2021; 23(5): 922-930 Nº de citas: 38 [doi:10.1007/s12094-020-02534-0]

Martin, M; Zielinski, C; Ruiz-Borrego, M; Carrasco, E; Turner, N; Ciruelos, EM; Munoz, M; Bermejo, B; Margeli, M; Anton, A; Kahan, Z; Csoszi, T; Casas, MI; Murillo, L; Morales, S; Alba, E; Gal-Yam, E; Guerrero-Zotano, A; Calvo, L; de la Haba-Rodriguez, J; Ramos, M; Alvarez, I; Garcia-Palomo, A; Bartlett, CH; Koehler, M; Caballero, R; Corsaro, M; Huang, X; Garcia-Saenz, JA; Chacon, JI; Swift, C; Thallinger, C; Gil-Gil, M.

Palbociclib in combination with endocrine therapy versus capecitabine in hormonal receptor-positive, human epidermal growth factor 2-negative, aromatase inhibitor-resistant metastatic breast cancer: a phase III randomised controlled trial-PEARL

ANNALS OF ONCOLOGY. 2021; 32(4): 488-499 Nº de citas: 121 [doi:10.1016/j.annonc.2020.12.013]

Trilla-Fuertes, L; Gamez-Pozo, A; Maurel, J; Garcia-Carbonero, R; Capdevila, J; G-Pastrian, L; Mendiola, M; Pena, C; Lopez-Vacas, R; Cuatrecasas, M; Garcia-Alfonso, P; Ramos-Ruiz, R; Llorens, C; Ghanem, I; Conill, C; Heredia-Soto, V; Campos-Barros, A; Vara, JAF; Feliu, J.

Description of the genetic variants identified in a cohort of patients diagnosed with localized anal squamous cell carcinoma and treated with panitumumab

Scientific Reports. 2021; 11(1): 7402-7402 Nº de citas: 3 [doi:10.1038/s41598-021-86966-w]

Conde, E; Earl, J; Crespo-Toro, L; Blanco-Agudo, C; Ramos-Munoz, E; Rodriguez-Serrano, EM; Avila, JCM; Salinas-Munoz, L; Serrano-Huertas, S; Ferreiro, R; Rodriguez-Garrote, M; Sainz, B; Massuti, B; Alfonso, PG; Benavides, M; Aranda, E; Garcia-Bermejo, ML; Carrato, A.

Biomarkers Associated with Regorafenib First-Line Treatment Benefits in Metastatic Colorectal Cancer Patients: REFRAME Molecular Study

Cancers. 2021; 13(7): Nº de citas: 14 [doi:10.3390/cancers13071710]